Ieq Capital LLC Acquires 484 Shares of CME Group Inc. (NASDAQ:CME)

Ieq Capital LLC boosted its stake in shares of CME Group Inc. (NASDAQ:CME) by 4.1% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,229 shares of the financial services provider’s stock after buying an additional 484 shares during the period. Ieq Capital LLC’s holdings in CME Group were worth $2,404,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CME. Aveo Capital Partners LLC purchased a new stake in shares of CME Group during the fourth quarter valued at approximately $226,000. 9258 Wealth Management LLC increased its holdings in shares of CME Group by 3.7% in the 4th quarter. 9258 Wealth Management LLC now owns 3,148 shares of the financial services provider’s stock worth $663,000 after purchasing an additional 113 shares in the last quarter. Gryphon Financial Partners LLC purchased a new position in shares of CME Group in the fourth quarter worth $547,000. Assetmark Inc. boosted its position in shares of CME Group by 16.9% during the fourth quarter. Assetmark Inc. now owns 15,059 shares of the financial services provider’s stock valued at $3,172,000 after buying an additional 2,180 shares during the last quarter. Finally, Franklin Resources Inc. increased its holdings in CME Group by 342.4% in the 4th quarter. Franklin Resources Inc. now owns 176,892 shares of the financial services provider’s stock worth $37,253,000 after buying an additional 136,905 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

NASDAQ:CME opened at $213.16 on Friday. The business’s 50-day simple moving average is $207.86 and its two-hundred day simple moving average is $207.45. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80. The stock has a market cap of $76.75 billion, a PE ratio of 24.25, a P/E/G ratio of 8.85 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the firm earned $2.30 EPS. The firm’s revenue was up 12.7% compared to the same quarter last year. As a group, analysts forecast that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.16%. CME Group’s payout ratio is 52.33%.

Insider Buying and Selling at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 price target on shares of CME Group in a report on Tuesday, August 20th. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price target on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Finally, Barclays upped their price objective on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $209.73.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.